STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,908,103 | -62.9% | 14,443,681 | 0.0% | 99.78% | +49.7% |
| Q2 2023 | $153,536,329 | +27.6% | 14,443,681 | 0.0% | 66.66% | +37.1% |
| Q1 2023 | $120,315,863 | +90149.3% | 14,443,681 | 0.0% | 48.62% | +14.7% |
| Q4 2022 | $133,315 | -99.9% | 14,443,681 | 0.0% | 42.40% | -19.0% |
| Q3 2022 | $185,457,000 | -2.8% | 14,443,681 | 0.0% | 52.34% | -34.4% |
| Q2 2022 | $190,801,000 | -37.2% | 14,443,681 | 0.0% | 79.84% | -1.4% |
| Q1 2022 | $304,039,000 | -12.3% | 14,443,681 | 0.0% | 80.96% | +5.6% |
| Q4 2021 | $346,504,000 | – | 14,443,681 | – | 76.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |